Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adam Jasilek"'
Autor:
Ross T. Campbell, Adam Jasilek, Harald Mischak, Esther Nkuipou‐Kenfack, Agnieszka Latosinska, Paul I. Welsh, Colette E. Jackson, Jane Cannon, Alex McConnachie, Christian Delles, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1595-1604 (2020)
Abstract Aims Measurement of B‐type natriuretic peptide (BNP) or N‐terminal pro‐BNP is recommended as part of the diagnostic workup of patients with suspected heart failure (HF). We evaluated the diagnostic and prognostic utility of the novel u
Externí odkaz:
https://doaj.org/article/ef46f42dcbe34cdba9bc08a266064c61
Autor:
Nicola Greenlaw, Paula McSkimming, Angela Henderson, Sally-Ann Cooper, Deborah Kinnear, Craig Melville, Colin McCowan, Linda Allan, Adam Jasilek
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Objectives To investigate mortality in adults with intellectual disabilities: rates, causes, place, demographic and clinical predictors.Design Cohort study with record linkage to death data.Setting General community.Participants 961/1023 (94%) adults
Externí odkaz:
https://doaj.org/article/65904a9dd7ac4fedb10a4efabefa9199
Autor:
Kerri E. McPherson, Kirsty Wiseman, Adam Jasilek, Kareena McAloney-Kocaman, Alina Morawska, Caroline Haig
In a randomized controlled trial, we tested the efficacy of Baby Triple P in a community sample of first-time parent couples. The intervention was developed to promote better mental health, a positive couple relationship, positive parenting, and a be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::224b4aa450308068a9b862b3fc7dfdb7
https://eprints.gla.ac.uk/273695/1/273695.pdf
https://eprints.gla.ac.uk/273695/1/273695.pdf
Autor:
Philippe Gabriel Steg, A. Darmon, Roberto Ferrari, Emmanuel Sorbets, Jean-Claude Tardif, Ian Ford, Gregory Ducrocq, Laurent J. Feldman, Kim Fox, Michal Tendera, Adam Jasilek
Publikováno v:
Clinical Cardiology
Background:\ud \ud The COMPASS trial showed a reduction of ischemic events with low-dose rivaroxaban and aspirin in chronic coronary syndromes (CCS) compared with aspirin alone, at the expense of increased bleeding.\ud \ud Hypothesis:\ud \ud The CHA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7036536b301be8b68570e8ca6b565849
https://doi.org/10.1002/clc.23505
https://doi.org/10.1002/clc.23505
Autor:
Adam Jasilek, Colette E. Jackson, Esther Nkuipou-Kenfack, Paul Welsh, John J.V. McMurray, Jane A. Cannon, Christian Delles, Agnieszka Latosinska, Ross T. Campbell, Harald Mischak, Alex McConnachie
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 4, Pp 1595-1604 (2020)
ESC Heart Failure, Vol 7, Iss 4, Pp 1595-1604 (2020)
Aims: \ud Measurement of B‐type natriuretic peptide (BNP) or N‐terminal pro‐BNP is recommended as part of the diagnostic workup of patients with suspected heart failure (HF). We evaluated the diagnostic and prognostic utility of the novel urina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e1b06a7e89dccb7b948ee8f4320cc3
https://eprints.gla.ac.uk/195078/1/195078.pdf
https://eprints.gla.ac.uk/195078/1/195078.pdf
Autor:
Matthew Taylor, Jeanette Kusel, Lindsay Claxton, Timothy Reason, D Trueman, Ruth Pulikottil-Jacob, Robert Hodgson, Rose Wickstead, Adam Jasilek
Publikováno v:
Advances in Therapy
Introduction The estimation of utility values for the economic evaluation of therapies for wet age-related macular degeneration (AMD) is a particular challenge. Previous economic models in wet AMD have been criticized for failing to capture the bilat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3568e887869e9032ec33356df93c35f6
https://doi.org/10.1007/s12325-017-0620-x
https://doi.org/10.1007/s12325-017-0620-x
Autor:
Michal Tendera, Jean-Claude Tardif, Ian Ford, Kim Fox, Zofia Parma, Roberto Ferrari, Adam Jasilek, Nicola Greenlaw, P. Gabriel Steg
Publikováno v:
European journal of heart failureReferences. 22(5)
AIM The contemporary incidence of heart failure (HF) in patients with chronic coronary syndrome is unclear. We aimed to study the incidence and predictors of cardiovascular (CV) death, HF hospitalization or new-onset HF not requiring hospitalization,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3862e425d9581c79d2576eadc35c32
https://pubmed.ncbi.nlm.nih.gov/32297414
https://pubmed.ncbi.nlm.nih.gov/32297414
Autor:
Jean-Claude Tardif, Laurent J. Feldman, Gregory Ducrocq, Ian Ford, A. Darmon, Michal Tendera, Kim Fox, Adam Jasilek, P.G. Steg, Roberto Ferrari, Emmanuel Sorbets
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:13
Background The COMPASS trial demonstrated efficacy of combination of aspirin and low dose rivaroxaban, compared to aspirin alone, but at the expense of increased bleeding. Purpose To evaluate the performance of the CHA2DS2VaSc (0–9), the REACH Recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2393eb96584ae26933eed1231fa0613
https://doi.org/10.1016/j.acvdsp.2019.09.020
https://doi.org/10.1016/j.acvdsp.2019.09.020
Autor:
Emmanuel Sorbets, Jean-Claude Tardif, Roberto Ferrari, Jean-Michel Juliard, P.G. Steg, Michal Tendera, A. Darmon, Adam Jasilek, Gregory Ducrocq, Ian Ford, Kim Fox
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:15
Background A previous analysis of the REACH Registry showed that 52.9% of stable vascular patients were eligible to COMPASS. However, data regarding eligibility to COMPASS in CAD patients from real life practice are scarce. Purpose To describe the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfd03f0ece477c2c84bd17873789a02c
https://doi.org/10.1016/j.acvdsp.2019.09.025
https://doi.org/10.1016/j.acvdsp.2019.09.025